CFS Investment Advisory Services LLC trimmed its holdings in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 51.2% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 27,831 shares of the company’s stock after selling 29,213 shares during the quarter. CFS Investment Advisory Services LLC’s holdings in Procter & Gamble were worth $4,820,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Itau Unibanco Holding S.A. purchased a new position in shares of Procter & Gamble during the 2nd quarter valued at approximately $28,000. Fairway Wealth LLC purchased a new position in Procter & Gamble in the second quarter valued at $29,000. POM Investment Strategies LLC acquired a new position in shares of Procter & Gamble in the second quarter worth about $34,000. Quest Partners LLC purchased a new stake in shares of Procter & Gamble during the 2nd quarter worth about $36,000. Finally, Fairfield Financial Advisors LTD purchased a new position in shares of Procter & Gamble in the 2nd quarter valued at about $44,000. Institutional investors and hedge funds own 65.77% of the company’s stock.
Insider Activity at Procter & Gamble
In other news, insider Balaji Purushothaman sold 12,800 shares of the company’s stock in a transaction on Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the transaction, the insider now directly owns 11,566 shares of the company’s stock, valued at $1,954,538.34. This represents a 52.53 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Susan Street Whaley sold 634 shares of the firm’s stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $108,826.10. Following the completion of the sale, the insider now owns 19,341 shares of the company’s stock, valued at $3,319,882.65. This trade represents a 3.17 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 160,693 shares of company stock worth $27,311,345 in the last three months. Insiders own 0.18% of the company’s stock.
Procter & Gamble Trading Up 1.0 %
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. Procter & Gamble’s revenue for the quarter was down .6% on a year-over-year basis. During the same period last year, the firm posted $1.83 EPS. On average, research analysts predict that The Procter & Gamble Company will post 6.94 EPS for the current year.
Procter & Gamble Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.33%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.
Analyst Ratings Changes
Several research firms have issued reports on PG. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $164.00 price objective on shares of Procter & Gamble in a report on Monday, October 21st. DZ Bank upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price objective for the company in a report on Thursday, August 29th. StockNews.com cut shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. JPMorgan Chase & Co. upped their price objective on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a report on Thursday, September 19th. Finally, Barclays lowered Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 target price on the stock. in a research report on Monday, September 30th. Nine analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and an average price target of $177.00.
Get Our Latest Stock Report on Procter & Gamble
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Articles
- Five stocks we like better than Procter & Gamble
- 5 discounted opportunities for dividend growth investors
- Oil’s Rally Could Boost These 3 Shipping Stocks
- EV Stocks and How to Profit from Them
- Symbotic Is Up Nearly 50% in 3 Months: Why It Can Keep Winning
- Stock Dividend Cuts Happen Are You Ready?
- QuantumScape: High-Risk, High-Reward Solid-State Battery Play?
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.